Expression of neuromedins S and U and their receptors in the hypothalamus and endocrine glands of the rat

International Journal of Molecular Medicine

Volumn 20, Issue 2, 2007, Pages 255-259

  Rucinski, Marcin ^a   Ziolkowska, Agnieszka ^a   Neri, Giuliano ^b   Trejter, Marcin ^a   Zemleduch, Tomasz ^a   Tyczewska, Marianna ^a   Nussdorfer, Gastone G ^b   Malendowicz, Ludwik K ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

Endocrine glands; Hypothalamus; Neuromedin S; Neuromedin U; Neuromedin U receptors; Rat

Indexed keywords

ISOPROTEIN; MEMBRANE PROTEIN; NEUROMEDIN S; NEUROMEDIN S RECEPTOR, RAT; NEUROMEDIN U; NEUROMEDIN U RECEPTOR; NEUROPEPTIDE; NEUROTRANSMITTER RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL; ARTICLE; ENDOCRINE GLAND; FEMALE; GENE EXPRESSION; GENETICS; HYPOTHALAMUS; MALE; METABOLISM; RAT; TISSUE DISTRIBUTION; WISTAR RAT;

ANIMALS; ENDOCRINE GLANDS; FEMALE; GENE EXPRESSION; HYPOTHALAMUS; MALE; MEMBRANE PROTEINS; NEUROPEPTIDES; PROTEIN ISOFORMS; RATS; RATS, WISTAR; RECEPTORS, NEUROTRANSMITTER; TISSUE DISTRIBUTION;

EID: 35448970675     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.20.2.255     Document Type: Article

References (49)

1. Tan CP, McKee KK, Liu QY, Palyha OC, Feighner SD, Hreniuk DL, Smith RG and Howard AD: Cloning and characterization of a human and murine T-cell orphan G-proteincoupled receptor similar to the growth hormone secretagogue and neurotensin receptors. Genomics 52: 223-229, 1998.
2. Fujii R, Hosoya M, Fukusami S, Kazamata Y, Habata Y Hinuma S, Onda H, Nishimura O and Fujino M: Identification of neuromedin U as the cognate ligand of the orphan G protein-coupled receptor FM-3. J Biol Chem 275: 21068-21074, 2000.
3. Howard AD, Wang R, Pong SS, Mellin TN, Strack A, Guan XM, Zeng Z, Williams DL Jr, Feighner SD, Nunes CN, Murphy B, Stair JN, Yu H, Jiang Q, Clements MK, Tan CP, McKee KK, Hreniuk DL, McDonald TP, Lynch KR, Evans JF, Austin CP, Caskey CT, Van der Ploeg LH and Liu Q: Identification of receptors for neuromedin U and its role in feeding. Nature 406: 70-74, 2000.
4. Kojima M, Maruno R, Nakazato M, Date Y, Murakami N, Hanada R, Matsuo H and Kangawa K: Purification and identification of neuromedin U as an endogenous ligand for an orphan receptor GPR66 (FM3). Biochem Biophys Res Commun 276: 435-438, 2000.
5. Hedrick JA, Morse K, Shan L, Qiao X, Pang L, Wang S, Laz T, Gustafson EL, Bayne M and Monsma JF: Identification of a human gastrointestinal tract and immune system receptor for the peptide neuromedin U. Mol Pharmacol 58: 870-875, 2000.
6. Szekeres PG, Muir AI, Spinage LD, Miller JE, Butler SI, Smith A, Rennie GL, Murdock PR, Fitzgerald LR, Wu H, McMillan LJ, Guerrera S, Vawter L, Elshourbagy NA, Mooney JL, Bergsma DJ, Wilson S and Chambers JK: Neuromedin U is a potent agonist at the orphan G protein-coupled receptor FM3. J Biol Chem 275: 20247-20250, 2000.
7. Ida T, Mori K, Miyazato M, Egi Y, Abe S, Nakahara K, Nishihara M, Kangawa K and Murakami N: Neuromedin S is a novel anorexigenic hormone. Endocrinology 146: 4217-4223, 2005.
8. Mori K, Miyazato M, Ida T, Murakami N, Serino R, Ueta Y, Kojima M and Kangawa K: Identification of neuromedin S and possible role in the mammalian circadian oscillator system. EMBO J 24: 325-335, 2005.
9. Shousha S, Nakahara K, Miyazato M, Kangawa K and Murakami N: Endogenous neuromedin U has anorectic effects in the Japanese quail. Gen Comp Endocrinol 140: 156-163, 2005.
10. Malendowicz LK, Nussdorfer GG, Nowak KW and Mazzocchi G: Effects of neuromedin U-8 on the rat pituitary-adrenocortical axis. In Vivo 7: 419-422, 1993.
11. Malendowicz LK: Role of neuromedins in the regulation of adrenocortical function. Horm Metab Res 30: 374-384, 1998.
12. Niimi M, Murao K and Taminato T: Central administration of neuromedin U activates neurons in ventrobasal hypothalamus and brainstem. Endocrine 16: 201-206, 2001.
13. Ozaki Y, Onaka T, Nakazato M, Saito J, Kanemoto K, Matsumoto T and Ueta Y: Centrally administered neuromedin U activates neurosecretion and induction of C-Fos messenger ribonucleic acid in the paraventricular and supraoptic nuclei of rat. Endocrinology 143: 4320-4329, 2002.
14. Wren AM, Small CJ, Abbott CR, Jethwa PH, Keneddy AR, Murphy KG, Stanley SA, Zollner AN, Ghatei MA and Bloom SR: Hypothalamic actions of neuromedin U. Endocrinology 143: 4227-4234, 2002.
15. Thompson EL, Murphy KG, Todd JF, Martin NM, Small CJ, Ghatei MA and Bloom SR: Chronic administration of NMU into the paraventricular nucleus stimulates the HPA axis but does not influence food intake or body weight. Biochem Biophys Res Commun 323: 65-71, 2004.
16. Ueta Y, Ozaki Y and Saito J: Novel G-protein coupled receptor ligands and neurohypophysial hormones. J Neuroendocrinol 16: 378-382, 2004.
17. Jethwa PH, Smith KL, Small CJ, Abbott CR, Darch SJ, Murphy KG, Seth A, Semjonous NM, Pate SR, Todd JF, Ghatei MA and Bloom SR: Neuromedin U partially mediates leptin-induced hypothalamo-pituitary-adrenal (HPA) stimulation and has a physiological role in the regulation of the HPA axis in the rat. Endocrinology 147: 2886-2892, 2006.
18. Novak CM, Zhang M and Levine JA: Neuromedin U in the paraventricular and arcuate hypothalamic nuclei increases non-exercise activity thermogenesis. J Neuroendocrinol 18: 594-601, 2006.
19. Hochól A, Belloni AS, Rucinski M, Ziolkowska A, Di Liddo R, Nussdorfer GG and Malendowicz LK: Expression of neuropeptides B and W and their receptors in endocrine glands of the rat. Int J Mol Med 18: 1101-1106, 2006.
20. Lacy PE and Kostianovsky M: Method for the isolation of intact islets of Langerhans from the rat pancreas. Diabetes 16: 35-39, 1967.
21. Albertin G, Carraro G and Nussdorfer GG: Human adrenomedullin gene silencing by short interfering RNAs: a preliminary study. Int J Mol Med 15: 579-583, 2005.
22. Andreis PG, Rucinski M, Neri G, Conconi MT, Petrelli L, Parnigotto PP, Malendowicz LK and Nussdorfer GG: Neuropeptides B and W enhance the growth of human adrenocortical carcinoma-derived NCI-H295 cells by exerting MAPK p42/p44- mediated proliferogenic and antiapoptotic effects. Int J Mol Med 16: 1021-1028, 2005.
23. Rucinski M, Andreis PG, Ziolkowska A, Nussdorfer GG and Malendowicz LK: Differential expression and function of beacon in the rat adrenal cortex and medulla. Int J Mol Med 16: 35-40, 2005.
24. Albertin G, Carraro G, Petrelli L, Guidolin D, Neri G and Nussdorfer GG: Endothelin-1 and adrenomedullin enhance the growth of human adrenocortical carcinoma-derived SW-13 cell line by stimulating proliferation and inhibiting apoptosis. Int J Mol Med 15: 469-474, 2005.
25. Albertin G, Rucinski M, Carraro G, Forneris M, Andreis PG, Malendowicz LK and Nussdorfer GG: Adrenomedullin and vascular endothelium growth factor genes are overexpressed in the regenerating rat adrenal cortex, and AM and VEGF reciprocally enhance their mRNA expression in cultured rat adrenocortical cells. Int J Mol Med 16: 431-435, 2005.
26. Rucinski M, Albertin G, Spinazzi R, Ziolkowska A, Nussdorfer GG and Malendowicz LK: Cerebellin in the rat adrenal gland: gene expression and effects of CER and [des- Ser1]CER on the secretion and growth of cultured adrencortical cells. Int J Mol Med 15: 411-415, 2005.
27. Rossi GP, Sticchi D, Giuliani L, Bernante P, Zavattero S, Pessina AC and Nussdorfer GG: Adiponectin receptor expression in the human adrenal cortex and aldosterone-producing adenomas. Int J Mol Med 17: 975-980, 2006.
28. Carraro G, Albertin G, Aragona F, Forneris M, Casale V, Spinazzi R and Nussdorfer GG: Age-dependent decrease in the ghrelin gene expression in the human adrenal cortex: a real time PCR study. Int J Mol Med 17: 319-321, 2006.
29. Rucinski M, Ziolkowska A, Hochól A, Pucher A, Macchi C, Belloni AS, Nussdorfer GG and Malendowicz LK: Estradiol and resveratrol stimulating effect on osteocalcin, but not osteonectin and collagen-1α gene expression in primary culture of rat calvarial osteoblast-like cells. Int J Mol Med 18: 565-570, 2006.
30. Ziolkowska A, Rucinski M, Tyczewska M, Belloni AS, Nowak M, Nussdorfer GG and Malendowicz LK: Downregulation of the beacon gene expression in the regenerating rat adrenal cortex. Peptides 27: 3216-3219, 2006.
31. Ziolkowska A, Tortorella C, Nussdorfer GG, Rucinski M, Majchrzak M and Malendowicz LK: Accumulation of steroidogenic acute regulatory protein mRNA and decrease in the secretory and proliferative activity of rat adrenocortical cells in the presence of proteasome inhibitors. Int J Mol Med 17: 865-868, 2006.
32. Domin J, Ghatei MA, Chohan P and Bloom SR: Characterization of neuromedin U like immunoreactivity in rat, porcine, guineapig and human tissue extracts using a specific radioimmunoassay. Biochem Biophys Res Commun 140: 1127-1134, 1986.
33. Domin J, Ghatei MA, Chohan P and Bloom SR: Neuromedin U: a study of its distribution in the rat. Peptides 8: 779-784, 1987.
34. Honzawa M, Sudoh T, Minamino N, Tohyama M and Matsuo H: Topographic localization of neuromedin U-like structures in the rat brain: an immunohistochemical study. Neuroscience 23: 1103-1122, 1987.
35. Ballesta J, Carlei F, Bishop AE, Steel JH, Gibson SJ, Fahey M, Hennessey R, Domin J, Bloom SR and Polak JM: Occurrence and developmental pattern of neuromedin U-immunoreactive nerves in the gastrointestinal tract and brain of the rat. Neuroscience 3: 797-816, 1988.
36. Steel JH, Van Noorden S, Ballesta J, Gibson SJ, Ghatei MA, Burrin J, Leonhardt U, Domin J, Bloom SR and Polak JM: Localization of 7B2, neuromedin B, and neuromedin U in specific cell types of rat, mouse, and human pituitary, in rat hypothalamus and in 30 human pituitary and extrapituitary tumors. Endocrinology 122: 270-282, 1988.
37. Domin J, Al-Madani AM, Desperbasques M, Bishop AE, Polak JM and Bloom SR: Neuromedin U-like immunoreactivity in the thyroid gland of the rat. Cell Tissue Res 260: 131-135, 1990.
38. Ahren B: Regulatory peptides in the thyroid gland: a review on their localization and function. Acta Endocrinol 124: 225-232, 1991.
39. Cimini V, Van Noorden S, Timson CM and Polak JM: Modulation of galanin and neuromedin U-like immunoreactivity in rat corticotropes after alteration of endocrine status. Cell Tissue Res 272: 137-146, 1993.
40. Ivanov TR, Lawrence CB, Stanley PJ and Luckman SM: Evaluation of neuromedin U actions in energy homeostasis and pituitary function. Endocrinology 143: 3813-3821, 2002.
41. Brighton PJ, Szekeres PG and Willars GB: Neuromedin U and its receptors: structure, function, and physiological roles. Pharmacol Rev 56: 231-248, 2004.
42. Brighton PJ, Szekeres PG, Wise A and Willars GB: Signaling and ligand binding by recombinant neuromedin U receptors: evidence for dual coupling to Galphaq/11 and Galphai and an irreversible ligand-receptor interaction. Mol Pharmacol 66: 1544-1556, 2004.
43. Raddatz R, Wilson AE, Artymyshyn R, Bonini JA, Borowsky B, Boteju LW, Zhou SQ, Kouranova EV, Nagorny R, Guevarra MS, Dai M, Lerman GS, Vaysse PJ, Branchek TA, Gerald C, Forray C and Adham N: Identification and characterization of two neuromedin U receptors differentially expressed in peripheral tissues and the central nervous system. J Biol Chem 275: 32452-32459, 2000.
44. Graham ES, Turnbull Y, Fotheringham P, Nilaweera K, Mercer JG, Morgan PJ and Barrett P: Neuromedin U and neuromedin U receptor-2 expression in the mouse and rat hypothalamus: effects of nutritional status. J Neurochem 87: 1165-1173, 2003.
45. Shan LX, Qiao XD, Crona JH, Behan J, Wang S, Laz T, Bayne M, Gustafson EL, Monsma FJ and Hedrick JA: Identification of a novel neuromedin U receptor subtype expressed in the central nervous system. J Biol Chem 275: 39482-39486, 2000.
46. Westfall TD, McCafferty GP, Pullen M, Gruver S, Sulpizio AC, Aiyar VN, Disa J, Contino LC, Mannan IJ and Hieble JP: Characterisation of neuromedin U effects in canine smooth-muscle. J Pharmacol Exp Ther 301: 987-992, 2001.
47. Hosoya M, Moriya T, Kawamata Y, Ohkubo S, Fujii R, Matsui H, Shintani Y, Fukusumi S, Habata Y, Hinuma S, Onda H, Nishimura O and Fujino M: Identification and functional characterization of a novel subtype of neuromedin U receptor. J Biol Chem 275: 29528-29532, 2000.
48. Shousha S, Nakahara K, Sato M, Mori K, Miyazato M, Kangawa K and Murakami N: Effect of neuromedin S on feeding regulation in the Japanese quail. Neurosci Lett 391: 87-90, 2006.
49. Vigo E, Roa J, Lopez M, Castellano JM, Fernandez-Fernandez R, Navarro VM, Pineda R, Aguilar E, Dieguez C, Pinilla L and Tena-Sempere M: Neuromedin S as novel putative regulator of luteinizing hormone secretion. Endocrinology 148: 813-823, 2007.